We are live on ! Find out more
ARTLW

Artelo Biosciences, Inc. Warrant

Delisted

ARTLW was delisted on the 17th of June, 2024.

4 hedge funds and large institutions have $26K invested in Artelo Biosciences, Inc. Warrant in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $24K → $26K (+$2K)

20% less funds holding

Funds holding: 54 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Verition Fund Management
1
Verition Fund Management
Connecticut
$15K
AGM
2
Alpine Global Management
New York
$6K
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$5K -$6.66K -15,931 -56%
WAM
4
Warberg Asset Management
Illinois
-$4K -16,403 Closed

ARTLW Hedge Fund Activity: Q1 2021 in Review

4 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q1 2021, worth a combined $26K — up 8.3% from $24K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ARTLW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Susquehanna International Group, cutting an estimated $6.66K.

  • 4 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q1 2021, down from 5 in Q4 2020.
  • Funds reported $26K of Artelo Biosciences, Inc. Warrant stock for Q1 2021, up 8.3% quarter-over-quarter.
  • 0 funds opened new Artelo Biosciences, Inc. Warrant positions in Q1 2021 and 1 closed out, a net change of -1 holder.
  • The largest Artelo Biosciences, Inc. Warrant seller in Q1 2021 was Susquehanna International Group, an estimated $6.66K sold.

Based on aggregated 13F filings for Q1 2021.